-
10 November 2011
Brazilians demand greater access to crucial HIV drug
Brazilian civil society will oppose a patent application today for the key HIV drug lopinavir/ritonavir (LPV/r), in an effort to allow access to more affordable generic versions of the medicine. The move is part of efforts to use all available public health provisions within international trade rules to increase access to the drug for people living with HIV/AIDS. The international medical humanitarian organisation Médecins Sans Frontières (MSF) welcomes this action.
— excerpt from today’s MSF press release on Brazilian civil society’s move to oppose a patent application by Abbott on lopinavir/ritonavir in order to ensure greater access to affordable generic versions of the medicine
More than 40,000 people in Brazil today take LPV/r, and this number is only expected to increase.
Web Updates
Regularly updated news feed of updates to the online version of Untangling the Web as well as related news articles.
